ESSA Pharma to Present at the JonesHealthcare Seaside Summit
ESSA Pharma (NASDAQ: EPIX), a clinical-stage pharmaceutical company aimed at developing innovative prostate cancer treatments, announced its participation in the JonesHealthcare Seaside Summit.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ESSA Pharma (NASDAQ: EPIX), a clinical-stage pharmaceutical company aimed at developing innovative prostate cancer treatments, announced its participation in the JonesHealthcare Seaside Summit. The event will take place on July 15, 2024, at 11:00 a.m. PT. The company's President and CEO, David R. Parkinson, will lead the presentation and join a panel discussion titled 'Innovations and Challenges in Prostate Cancer' at 9:00 a.m. PT. The presentation will be webcast live on the Investors/Events & Presentations section of the ESSA Pharma website and will remain archived for 90 days post-event. However, the panel discussion will not be available via webcast.
Details
News Market Reaction – EPIX
The recorded move for EPIX in the trading session of this news was -3.68%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
David R. Parkinson, President and Chief Executive Officer, will host the presentation and will also participate in a panel discussion titled "Innovations and Challenges in Prostate Cancer" at 9:00 a.m. PT.
A live webcast of the presentation can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. Following the event, the webcast will be archived on the ESSA website for 90 days. The panel, "Innovations and Challenges in Prostate Cancer," will not be webcast.
About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essaphrma.com, and follow us on X and LinkedIn.
Contacts
ESSA Pharma Inc.
Peter Virsik, Chief Operating Officer
778.331.0962
pvirsik@essapharma.com
Investors and Media:
Argot Partners
212.600.1902
essa@argotpartners.com
View original content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-the-joneshealthcare-seaside-summit-302190883.html
SOURCE ESSA Pharma Inc
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.